Metacare

118000 · KOSPI · Industrials · SMALL CAP

Updated results.

Metacare updated its previously filed consolidated results for FY2025: revenue of US$21.9M (+62.42% year on year), operating profit of US$882K (−11.97% year on year) and a net loss of US$141K (from a profit a year earlier).

Earnings([Amended] Change of 30% or more in revenue or profit/loss structure (15% for large companies))· FILED 2026-03-16· RCEPT 20260316802737

US$21.9MRevenue
+62.42%Revenue vs a year earlier
US$882KOperating profit

Converted at 1 USD ≈ ₩1,501.75 (filing-date rate, 2026-03-16 close)

What happened

Metacare updated its previously filed consolidated results for FY2025: revenue of US$21.9M (+62.42% year on year), operating profit of US$882K (−11.97% year on year) and a net loss of US$141K (from a profit a year earlier).

Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.

RevenueUS$21.9M
Revenue vs a year earlier+62.42%
Operating profitUS$882K
Net income−US$141K
PeriodFY2025 (consolidated)
Filed2026-03-16, [Amended] Change of 30% or more in revenue or profit/loss structure (15% for large companies)
SourceDART rcept 20260316802737 → open original filing

Versions of this filing

  1. 2026-02-06Original
  2. 2026-03-16Amendment 1 (this page)

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-03-16 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.